- Report
- March 2024
- 182 Pages
Global
From €3237EUR$3,374USD£2,781GBP
€3596EUR$3,749USD£3,090GBP
- Report
- November 2023
- 175 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,030GBP
- Report
- March 2022
- 300 Pages
Global
From €4796EUR$5,000USD£4,120GBP
- Report
- October 2020
Global
From €3837EUR$4,000USD£3,296GBP
- Report
- June 2022
- 120 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Report
- February 2022
- 32 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Report
- October 2023
- 119 Pages
Global
From €3500EUR$3,908USD£3,112GBP
- Drug Pipelines
- July 2020
- 45 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Report
- March 2024
- 132 Pages
Global
From €911EUR$950USD£783GBP
The Diuretic Agent market is a subset of the Urological Disorders Drugs market, which focuses on medications used to treat conditions related to the urinary system. Diuretics are used to reduce the amount of fluid in the body, and are commonly prescribed to treat high blood pressure, heart failure, and kidney disease. They work by increasing the amount of salt and water that is excreted in the urine. Diuretics can also be used to reduce swelling caused by certain medical conditions.
Diuretics are available in a variety of forms, including tablets, capsules, and injectables. Commonly prescribed diuretics include furosemide, hydrochlorothiazide, and spironolactone.
The Diuretic Agent market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more
